Submissions

Login or Register to make a submission.

Submission Preparation Checklist

As part of the submission process, authors are required to check off their submission's compliance with all of the following items, and submissions may be returned to authors that do not adhere to these guidelines.
  • The manuscript has not been previously published, nor is it before another journal for consideration (or an explanation has been submitted in the Comments to the Editor).
  • Manuscript documents submitted are in the form of doc or docx files, with a maximum document size of 2MB. File naming: title_principal author name.
  • If available, URLs for references have been provided.
  • Manuscripts are single-spaced; use Times New Roman 12-point font; italicize foreign language, not underline it (except with URL addresses); and all illustrations, figures, and tables are placed in the text at the appropriate place, not at the end.
  • Manuscripts adhere to the style and bibliographic requirements outlined in the Author Guidelines, found in Manuscript Submission section.
  • In addition to submitting the manuscript, please also attach supporting documents including Cover Letter for Publication, Similarity Agreement Letter, and Informed Consent Case Report (specifically for Case Report manuscripts). Supporting documents are available at: https://bit.ly/AuthorformCDK.

Author Guidelines

Cermin Dunia Kedokteran (CDK) accepts articles that discuss various aspects of medicine, pharmacy, and health. Articles sent to the Editor are articles that are specifically for publication by CDK (have not been published in other journals); if they have been discussed or read at scientific meetings, please provide information about the name, place, and time of the meeting.

GENERAL GUIDELINES
Articles should be written in Indonesian or English. If using the Indonesian language, it should follow the applicable Indonesian language rules (referring to the General Guidelines for Improved Indonesian Spelling, General Guidelines for the Formation of the Big Indonesian Dictionary). Medical terms should use standardized Indonesian terms as much as possible, or be given their equivalent in Indonesian. The length of the article ranges from 2000-3000 words, written with MS Word program, Times New Roman font size 12. The article will be checked with Turnitin application, and the maximum similarity index limit is 25%.

ABSTRACT AND KEYWORDS
Each article must be accompanied by an abstract in Indonesian and English, accompanied by 3-5 keywords arranged alphabetically. Abstracts are written in 1 (one) paragraph and, for research articles, are unstructured in the introduction, methods, results, discussion (IMRAD) format. The maximum length of the abstract is 200 words. If it is not available, the Editor has the right to make his own abstract in Indonesian and English.

AUTHOR'S NAME AND INSTITUTION
Name(s) of the author(s): Listed in full (not abbreviated), along with professional titles (General Practitioner, Specialist Doctor Education Program, Specialist Doctor).
Author's Institution: Information on the institution/faculty/institute where they work and e-mail address.

TABLE/GRAPHIC/PICTURE/CHART
Tables/graphics/images/charts that complement the article are made as clear as possible and sent separately in JPG format (minimum resolution of 150 dpi with actual size). Information on the table/graphic/image/chart should be written in Indonesian as much as possible.

LITERATURE
The bibliography is organized according to Vancouver rules. References are numbered in the order in which they appear in the article. If the authors are six or fewer, list all; if seven or more, list the first six and add et al. A minimum of 15 pieces of literature, published within the last 10 years or more recent. There should be more primary literature (from journals, a minimum proportion of 40%) than secondary literature. An example of a literature review format according to Vancouver rules:

JOURNAL
- Standard

1. Halpern SD, Ubel PA.Solid-organ transplantation in HIV-infected patients. N Engl J Med. 2002;347:284-7.
2. Skalsky  K,  Yahav  D,  Bishara  J,  Pitlik  S,  Leibovici  L,  Paul  M.  Treatment  of  human brucellosis:  systematic  review  and  meta-analysis  of  randomised  controlled  trials. BMJ. 2008; 36(7646):701-4.
3. Rose ME, Huerbin MB, Melick J, Marion DW, Palmer AM, Schiding JK, et al. Regulation of  interstitial  excitatory  amino  acid  concentrations  after  cortical  contusion  injury. Brain Res. 2002;935(1-2):40-6.

- Organization as an Author

1. American Diabetes Association. Diabetes update. Nursing. 2003;Suppl:19-20, 24.
2. Parkinson  Study  Group.  A  randomized  placebo-controlled  trial  of  rasagiline in levodopatreated  patients  with  Parkinson  disease  and  motor  fluctuations:  the PRESTO study. Arch Neurol. 2005;62(2):241-8.

- No Author Name

Pelvic floor exercise can reduce stress incontinence. Health News. 2005;11(4):11.
- Volume with Supplements

Geraud G, Spierings EL, Keywood C. Tolerability and safety of frovatriptan with shortand long-term use for treatment of migraine and in comparison with sumatriptan. Headache. 2002;42 Suppl 2:93-9.

- Edition with Supplements

Glauser  TA.  Integrating  clinical  trial  data  into  clinical  practice. Neurology. 2002;58(12 Suppl 7):6-12.

- Electronic Journal

Sillick TJ, Schutte NS. Emotional intelligence and self-esteem mediate between perceived early parental love and adult happiness. E-Jnl Appl Psych [serial on the Internet]. 2006 [cited 2010 Aug 6];2(2):38-48. Available from: http://ojs.lib.swin.edu.au/index.php/ejap/article/view/71/100.

BOOK
- Single Author/Editor

1.1. Hoppert M. Microscopic techniques in biotechnology. Weinheim: Wiley-VCH; 2003.
2.2. Storey KB, editors. Functional metabolism: regulation and adaptation. Hoboken (NJ): J. Wiley & Sons; 2004.

- More than One Author/Editor

1.1. Lawhead JB, Baker MC. Introduction to veterinary science. Clifton Park (NY): Thomson Delmar Learning; 2005.
2.2. Gilstrap LC, Cunningham FG, Van Dorsten JP, editors. Operative obstetrics. 2nd ed. New York: McGraw-Hill; 2002.
- Edition with Volume

Lee GR, Bithell TC, Foerster J, Athens JW, Lukens JN, editors. Wintrobes clinical hematology. 9th ed. Vol 2. Philadelphia: Lea & Febiger; 1993.

- Chapter in Book

Ford  HL,  Sclafani  RA,  Degregori  J.  Cell  cycle  regulatory  cascades.  In:  Stein  GS,  Pardee  AB, editors. Cell cycle and growth control: biomolecular regulation and cancer. 2nd ed. Hoboken (NJ): Wiley-Liss; 2004. p. 42-67.

CONFERENCE PROCEEDINGS
Harnden P, Joffe JK, Jones WG, editor. Germ cell tumor V: Proceedings of the 5th Germ Cell Tumors conference; 2001 Sep 13-15; Leeds, UK. New York: Springer; 2002.

CONFERENCE PAPERS
Christensen S, Oppacher F. Statistical analysis of Koza's computational efforts for genetic programming. In: Foster JA, Lutton E, Miller J, Ryan C, Tettamanzi AG, editors. Genetic programming: EuroGP 2002: Proceedings of the 5th European Conference on Genetic Programming; 2002 Apr 3-5; Kinsdale, Ireland. Berlin: Springer; 2002. p. 182-91.

ARTICLE SUBMISSION
Articles are sent to the editor in softcopy to this website.

All statements in the article are the responsibility of the author. The editor reserves the right to change the language without changing the content. Unpublished articles are returned to the author upon request. Given that CDK can now be accessed via the internet (online), articles that have been published will certainly be more easily downloaded and utilized by a wider audience. Further correspondence will be conducted via e-mail.

The writings in this magazine are the views/opinions of each author and do not necessarily represent the views or policies of the agency/institution where the author works.

Articles

Section default policy

Privacy Statement

This Privacy Policy ("Privacy Policy") describes the privacy practices of the cdkjournal website with respect to use of the website, which is intended for use by healthcare professionals, including cdkjournal's information and feature services (collectively, the "Feature Services"). This Privacy Policy does not apply to our properties and services that display a link to a different Privacy Policy.

We provide feature services as professional resources intended to enhance scientific insights to support higher quality services to Users. Users may choose whether or not to use the feature services. If the User chooses to use the feature services, it must agree to the cdkjournal Terms of Use which is a contract between cdkjournal and the User. By agreeing to the cdkjournal Terms of Use, the User confirms that it has read and understood this Privacy Policy.

By using the feature services, User acknowledges that we will store, use, and process User data from the cdkjournal website. If User does not want us to collect and use data about User as described in this Privacy Policy, then User should not use the feature services.